A new trading day began on Friday, with Puma Biotechnology Inc (NASDAQ: PBYI) stock price down -19.06% from the previous day of trading, before settling in for the closing price of $2.99. PBYI’s price has ranged from $2.22 to $7.73 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -0.59% over the last five years. Meanwhile, its annual earnings per share averaged -33.33%. With a float of $35.19 million, this company’s outstanding shares have now reached $47.65 million.
The firm has a total of 185 workers. Let’s measure their productivity. In terms of profitability, gross margin is 65.87%, operating margin of 14.78%, and the pretax margin is 11.25%.
Puma Biotechnology Inc (PBYI) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Puma Biotechnology Inc is 28.31%, while institutional ownership is 54.30%. The most recent insider transaction that took place on Aug 12 ’24, was worth 81,466. In this transaction Director of this company sold 23,358 shares at a rate of $3.49, taking the stock ownership to the 47,000 shares. Before that another transaction happened on Aug 12 ’24, when Company’s Director proposed sale 23,358 for $3.76, making the entire transaction worth $87,826.
Puma Biotechnology Inc (PBYI) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -33.33% per share during the next fiscal year.
Puma Biotechnology Inc (NASDAQ: PBYI) Trading Performance Indicators
Here are Puma Biotechnology Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.40. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.39. Likewise, its price to free cash flow for the trailing twelve months is 2.85.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.47, a number that is poised to hit 0.09 in the next quarter and is forecasted to reach 0.34 in one year’s time.
Technical Analysis of Puma Biotechnology Inc (PBYI)
Analysing the last 5-days average volume posted by the [Puma Biotechnology Inc, PBYI], we can find that recorded value of 1.05 million was better than the volume posted last year of 0.47 million. As of the previous 9 days, the stock’s Stochastic %D was 17.10%. Additionally, its Average True Range was 0.27.
During the past 100 days, Puma Biotechnology Inc’s (PBYI) raw stochastic average was set at 10.24%, which indicates a significant increase from 6.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 115.10% in the past 14 days, which was higher than the 85.57% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.73, while its 200-day Moving Average is $3.94. Now, the first resistance to watch is $2.84. This is followed by the second major resistance level at $3.25. The third major resistance level sits at $3.50. If the price goes on to break the first support level at $2.18, it is likely to go to the next support level at $1.93. Now, if the price goes above the second support level, the third support stands at $1.52.
Puma Biotechnology Inc (NASDAQ: PBYI) Key Stats
With a market capitalization of 96.14 million, the company has a total of 49,088K Shares Outstanding. Currently, annual sales are 235,640 K while annual income is 21,590 K. The company’s previous quarter sales were 80,540 K while its latest quarter income was 20,320 K.
